Back to search results

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

Abroad (travel likely)RecruitingPHASE1

Conditions

Atopic Dermatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • First OC Dermatology, Irvine, California, United States

  • OptiSkin Medical, New York, New York, United States

  • Equity Medical, LLC, The Bronx, New York, United States

  • Fremantle Dermatology, Fremantle, Western Australia, Australia

  • Linear Clinical Research, Perth, Western Australia, Australia

  • Optimal Clinical Trials Central Auckland, Grafton, Auckland, New Zealand

    Contact: Study coordinator (Arna Letica)

  • Aotearoa Clinical Trials, Otahuhu, Auckland, New Zealand

  • Pacific Clinical Research Network (PCRN) - Auckland, Takapuna, Auckland, New Zealand

    Contact: Study coordinator (Paul Hamilton)

  • Optimal Clinical Trials Ltd - Christchurch, Christchurch, Christchurch, New Zealand

  • Pacific Clinical Research Network (PCRN) Wellington, Upper Hutt, New Zealand

    Contact: Study coordinator (Tim Humphrey)

  • Wojewódzki Specjalistyczny Szpital im. Dr. Wł. Biegańskiego w Łodzi, Lodz, Poland

  • Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie, Rzeszów, Poland

  • Państwowy Instytut Medyczny MSWiA, Warsaw, Poland

  • Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska, Wroclaw, Poland

Study leads

  • Lisa Li

    Study Director

    Bambusa Therapeutics, Inc.

View source on ClinicalTrials.gov(opens in a new tab)